Financial Network Wealth Advisors LLC Vaxcyte, Inc. Transaction History
Financial Network Wealth Advisors LLC
- $91.4 Billion
- Q3 2025
A detailed history of Financial Network Wealth Advisors LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Financial Network Wealth Advisors LLC holds 15 shares of PCVX stock, worth $684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15Holding current value
$684% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
310Shares Held
139MCall Options Held
199KPut Options Held
130K-
Janus Henderson Group PLC London, X014.7MShares$671 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$563 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA12MShares$546 Million8.5% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$454 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6MShares$274 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.71B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...